insights_auto
Why is AGIO down ४.०३%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २७.६०
arrow_downward
-४.०३%(-१.१६) 1D
US$ २७.६०
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
KPAX News
·
१ घण्टा पहिले
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
FXStreet
·
१ घण्टा पहिले
Dow Jones Industrial Average drops for a fifth day as AI rout widens
marketscreener.com
·
४२ मिनेट पहिले
S&P 500, Dow Sink Into Correction Territory as Investors Seek Treasury Cover Amid Plunging Big-Tech
finance.biggo.com
·
१ घण्टा पहिले
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc